Public companyPROBABLEBaseline coverage

Tempus AI, Inc.

COMPANY-TEMPUS_AI-001 · observed August 4, 2026

A healthcare data and technology company applying AI to precision medicine and patient care.

Data & toolingAI products

Evidence boundary

This baseline is projected from the governed Markets research record. Listing identity, AI-role evidence and market context are available now; products, people, headquarters and relationship entities require separate source-level admission.

VCAI-COMPANY-REGISTRY-001

Location and contact

Where to find Tempus AI.

SEC-recorded business address

600 WEST CHICAGO AVENUE, SUITE 510, CHICAGO, Il, 60654

SRC-TEMPUS_AI-SEC-SUBMISSIONS

Official presence

Business address, phone and investor relations are projected only when explicitly present in the SEC issuer record. Social channels, email and headquarters interpretation require separate first-party review.

External market projection

TEM · 30-day price trajectory

External market data remains a dated projection attached to the company—it does not define company identity.

$47.05

latest close

-21.93%

30 days

Observed 2026-08-05T05:32:58.314Z · close prices · USDProvider source

Research thesis

What this company is in the AI economy.

Tempus AI, Inc. is admitted to the public AI company universe as data & tooling. The classification describes its observed operating role in the AI economy; it does not convert the issuer into a pure-play AI company or an investment recommendation.

Knowledge-bearing claims

Important assertions stay explainable.

3 material claims

Claim 01 · Public issuer identity

Nasdaq: TEM

The reviewed market record resolves the issuer, exchange and ticker against primary filing or investor evidence.

SRC-REAL-009-A SRC-REAL-009-B

Claim 02 · Primary AI-economy role

Data & tooling

The annual filing identifies Tempus AI, its TEM listing and its technology and data business in precision medicine.

SRC-REAL-009-A SRC-REAL-009-B

Claim 03 · SEC issuer record

Tempus AI, Inc. · CIK 0001717115

Regulator-recorded issuer identity from the SEC submissions endpoint. It does not establish AI exposure or investment merit.

SRC-TEMPUS_AI-SEC-SUBMISSIONS

Products and operating surfaces

Products are independent entities linked to the company. They are not aliases for the organization itself.

Product coverage pending

No product has passed entity identity and source review for this profile yet.

People

Andrew Polovin

Executive Vice President, Chief Legal Officer and Secretary

Tempus AI, Inc.'s DEF 14A identifies Andrew Polovin as Executive Vice President, Chief Legal Officer and Secretary.

Open person profile